Education, EUGLOH, Research
SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy
… are the most promising drugs, they are associated with side effects in around 70% of treated patients, such called … traditional cancer therapies, and typically have delayed onset and prolonged duration. Some of them can be severe and … 24 Feb 2025 - 5 May 2025 Conditions Academic Staff, Master students, PhD students, Researchers … SPOC MIRACIP: …Published on: Thu 20/02/2025 - 15:07